CORC

浏览/检索结果: 共9条,第1-9条 帮助

已选(0)清除 条数/页:   排序方式:
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2017, 卷号: 35, 期号: 22
作者:  Shah, Manish A.;  Xu, Rui-hua;  Bang, Yung-Jue;  Hoff, Paulo M.;  Liu, Tianshu
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib 期刊论文
2017, 卷号: 16, 期号: 1, 页码: 228-238
作者:  Press, Michael F.;  Ellis, Catherine E.;  Gagnon, Robert C.;  Grob, Tobias J.;  Buyse, Marc
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC-A Randomized Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2016, 卷号: 34, 期号: 5
作者:  Hecht, J. Randolph;  Bang, Yung-Jue;  Qin, Shukui K.;  Chung, Hyun C.;  Xu, Jianming M.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/06
Post-hoc analyses of overall survival (OS) and progression-free survival (PFS) in the TRIO-013/LOGiC trial of lapatinib (L) in combination with capecitabine plus oxaliplatin (CapeOx) 会议论文
作者:  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Choel;  Xu, Jian-Ming;  Park, Joon Oh
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/19
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2014, 卷号: 32, 期号: 19
作者:  Satoh, Taroh;  Xu, Rui-Hua;  Chung, Hyun Cheol;  Sun, Guo-Ping;  Doi, Toshihiko
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study 期刊论文
2014, 卷号: 32, 期号: 19, 页码: 2039-U89
作者:  Satoh, Taroh;  Xu, Rui-Hua;  Chung, Hyun Cheol;  Sun, Guo-Ping;  Doi, Toshihiko
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13
Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial. 会议论文
作者:  Hecht, J. Randolph;  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Chul;  Xu, Jian-Ming
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/19
Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial. 会议论文
作者:  Hecht, J. Randolph;  Bang, Yung-Jue;  Qin, Shukui;  Chung, Hyun-Chul;  Xu, Jian-Ming
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
QUALITY OF LIFE IN PATIENTS WITH ADVANCED GASTRIC CANCER ENROLLED IN THE INTERNATIONAL, PHASE 3 GRANITE-1 STUDY 会议论文
作者:  Ajani, Jaffer;  Li, Jin;  Satoh, Taroh;  Nishina, Tomohiro;  Alarcon-Rozas, A.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace